Effects of Amentoflavone-Standardized Juniperus oxycedrus Fruit Extract on Systemic Redox and Hemodynamic Responses in Rat Endotoxemia
Endotoxemia-associated coagulopathy integrates inflammation, oxidative stress, circulatory dysfunction, fibrin turnover, and organ injury. This study evaluated an amentoflavone-standardized methanolic Juniperus oxycedrus fruit extract in lipopolysaccharide (LPS)-induced endotoxemia in rats and explored candidate targets using network pharmacology and molecular docking. Male Wistar rats were assigned to Control, LPS, LPS + aspirin (200 mg/kg), LPS + J. oxycedrus 100 mg/kg, or LPS + J. oxycedrus 200 mg/kg groups (n = 10/group). HPLC-DAD, thrombo-inflammatory biomarkers, systemic redox indices, antioxidant defenses, hemodynamic and physiological variables, hepatic and renal injury markers, apelin, lung wet/dry ratio, and descriptive histopathology were integrated. The extract contained approximately 0.41% amentoflavone. Network analysis identified 139 core targets, and docking predicted favorable binding poses for amentoflavone–MMP-9 (−9.5 kcal/mol) and luteolin–COX-2 (−9.4 kcal/mol). LPS increased D-dimer, oxidative injury, IL-6, lactate, ALT, AST, and creatinine and reduced MAP, core temperature, apelin, and antioxidant defenses. Both extract doses reduced D-dimer; 200 mg/kg produced the broadest numerical systemic response, lowering MDA by 51.6%, TOS by 50.4%, IL-6 by 65.1%, lactate by 59.2%, ALT by 54.3%, AST by 52.4%, and creatinine by 50.8% versus LPS, while increasing MAP by 46.3%, SOD by 87.4%, CAT by 86.8%, GPx-1 by 102.4%, TAS by 80.4%, and apelin by 132.8%. TxA2, tissue factor, BAL cytokines, and lung wet/dry ratio did not show a consistent extract-related improvement. The findings support a multi-domain association between J. oxycedrus treatment and improved systemic redox, perfusion, inflammatory, and organ-injury profiles, while the docking results remain hypothesis-generating and do not establish target engagement. Responses were endpoint-specific; uniform dose dependence, statistically confirmed between-dose superiority, comprehensive anticoagulation, and definitive pulmonary protection were not established.
Authors
- Bülent Bayraktar (ORCID: https://orcid.org/0000-0002-2335-9089)
- Doğukan Özen (ORCID: https://orcid.org/0000-0003-1943-2690)
- Gülbahar Böyük (ORCID: https://orcid.org/0000-0002-3453-2967)
- Ümmü Gülşen Bozok (ORCID: https://orcid.org/0000-0002-2016-7305)
- Burçin Ergene Öz (ORCID: https://orcid.org/0000-0001-6927-6652)
- Fatma Uysal Çınar (ORCID: https://orcid.org/0000-0002-9176-326X)
Institutions
- Bayburt University (TR)
- Ankara University (TR)
- Ankara Medipol Üniversitesi (TR)
Publication Details
- Journal
- Antioxidants
- Published
- 2026-11-17
- DOI
- https://doi.org/10.3390/antiox15111494
- Primary Topic
- Medicinal plant effects and applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00